| Year |
Citation |
Score |
| 2021 |
Korkmaz E, Balmert SC, Sumpter TL, Carey CD, Erdos G, Falo LD. Microarray patches enable the development of skin-targeted vaccines against COVID-19. Advanced Drug Delivery Reviews. 171: 164-186. PMID 33539853 DOI: 10.1016/j.addr.2021.01.022 |
0.305 |
|
| 2020 |
Falo LD. Advances in skin science enable the development of a COVID-19 vaccine. Journal of the American Academy of Dermatology. 83: 1226-1227. PMID 32485211 DOI: 10.1016/J.Jaad.2020.05.126 |
0.335 |
|
| 2020 |
Erdos G, Balmert SC, Carey CD, Falo GD, Patel NA, Zhang J, Gambotto A, Korkmaz E, Falo LD. Improved cutaneous genetic immunization by microneedle array delivery of an adjuvanted adenovirus vaccine. The Journal of Investigative Dermatology. PMID 32330464 DOI: 10.1016/J.Jid.2020.03.966 |
0.379 |
|
| 2020 |
Kim E, Erdos G, Huang S, Kenniston TW, Balmert SC, Carey CD, Raj VS, Epperly MW, Klimstra WB, Haagmans BL, Korkmaz E, Falo LD, Gambotto A. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development. Ebiomedicine. 102743. PMID 32249203 DOI: 10.1016/J.Ebiom.2020.102743 |
0.335 |
|
| 2020 |
Morelli AE, Sumpter TL, Rojas-Canales DM, Bandyopadhyay M, Chen Z, Tkacheva O, Shufesky WJ, Wallace CT, Watkins SC, Berger A, Paige CJ, Falo LD, Larregina AT. Neurokinin-1 Receptor Signaling Is Required for Efficient Ca Flux in T-Cell-Receptor-Activated T Cells. Cell Reports. 30: 3448-3465.e8. PMID 32160549 DOI: 10.1016/J.Celrep.2020.02.054 |
0.346 |
|
| 2020 |
Korkmaz E, Falo LD. Spherical Nucleic Acids as Emerging Topical Therapeutics: A Focus on Psoriasis Journal of Investigative Dermatology. 140: 278-281. PMID 31980061 DOI: 10.1016/J.Jid.2019.07.683 |
0.301 |
|
| 2020 |
Castanha PM, Erdos G, Watkins SC, Falo LD, Marques ET, Barratt-Boyes SM. Reciprocal immune enhancement of dengue and Zika virus infection in human skin. Jci Insight. PMID 31910161 DOI: 10.1172/Jci.Insight.133653 |
0.416 |
|
| 2020 |
Li Y, Zhang J, Falo LD, Larregina A, Sumpter T. 365 The MrgprB2/X2 is regulated by the neurokinin 2 receptor in mast cells in the skin Journal of Investigative Dermatology. 140. DOI: 10.1016/J.Jid.2020.03.372 |
0.309 |
|
| 2020 |
Balmert SC, Carey CD, Erdos G, Korkmaz E, Little SR, Falo LD. 101 Engineering the skin with microneedle arrays to induce immune tolerance Journal of Investigative Dermatology. 140. DOI: 10.1016/J.Jid.2020.03.103 |
0.371 |
|
| 2020 |
Mizes A, Carey CD, Friedman B, Zhang J, Korkmaz E, Balmert S, Erdos G, Falo LD. 082 Topical chemo-immunotherapy of melanoma Journal of Investigative Dermatology. 140. DOI: 10.1016/J.Jid.2020.03.084 |
0.336 |
|
| 2020 |
Bandyopadhyay M, Morelli AE, Ward NL, Erdos G, Sumpter T, Balmert S, Tkacheva O, Shufesky W, Falo LD, Larregina A. 060 Delivery of contact sensitizers and neurokinin 1 receptor antagonists by microneedle arrays targets different skin cells to abrogate contact dermatitis Journal of Investigative Dermatology. 140. DOI: 10.1016/J.Jid.2020.03.062 |
0.327 |
|
| 2020 |
You J, Hao R, Hao X, Falo LD, Kim E, Carey CD, Erdos G, Gambotto A, You Z. 052 Targeting keratinocytes to potentiate non-viral DNA skin immunization Journal of Investigative Dermatology. 140. DOI: 10.1016/J.Jid.2020.03.054 |
0.372 |
|
| 2019 |
Balmert SC, Carey CD, Falo GD, Sethi SK, Erdos G, Korkmaz E, Falo LD. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31756393 DOI: 10.1016/J.Jconrel.2019.11.023 |
0.422 |
|
| 2019 |
Shurin GV, Kruglov O, Ding F, Lin Y, Hao X, Keskinov AA, You Z, Lokshin AE, LaFramboise WA, Falo LD, Shurin MR, Bunimovich YL. Melanoma-induced reprogramming of Schwann cell signaling aids tumor growth. Cancer Research. PMID 30914431 DOI: 10.1158/0008-5472.Can-18-3872 |
0.366 |
|
| 2019 |
You J, Hao X, Falo LD, Hao R, You Z. 086 Targeting the skin microenvironment for effective non-viral DNA immunization Journal of Investigative Dermatology. 139. DOI: 10.1016/J.Jid.2019.03.162 |
0.377 |
|
| 2018 |
Geskin LJ, Akilov OE, Schowalter MK, Falo LD. Interferon-α2b-induced STAT3 suppression in myeloid-derived suppressor cells in mycosis fungoides. Cancer Immunology, Immunotherapy. 67: 1177-1178. PMID 29619509 DOI: 10.1007/S00262-018-2156-6 |
0.346 |
|
| 2018 |
Geskin LJ, Damiano JJ, Patrone CC, Butterfield LH, Kirkwood JM, Falo LD. Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma. Melanoma Research. PMID 29543704 DOI: 10.1097/Cmr.0000000000000441 |
0.429 |
|
| 2018 |
You JR, Hao R, Falo LD, Chen G, Hao X, Carey C, You Z. Abstract 725: Targeting the skin microenvironment for effective cancer vaccines Cancer Research. 78: 725-725. DOI: 10.1158/1538-7445.Am2018-725 |
0.492 |
|
| 2018 |
Erdos G, Falo G, Korkmaz E, Ozdoganlar B, Falo LD. 120 Microneedle array delivery of skin targeted adenovector vaccines Journal of Investigative Dermatology. 138. DOI: 10.1016/J.Jid.2018.03.124 |
0.356 |
|
| 2018 |
Sumpter T, Rojas-Canales D, Tkacheva O, Shufesky W, Falo L, Morelli A, Larregina A. 055 Development of contact dermatitis in mice requires T cell signaling via the neurokinin 1 receptor at the site of dendritic cell T cell synapse Journal of Investigative Dermatology. 138: S10. DOI: 10.1016/J.Jid.2018.03.059 |
0.341 |
|
| 2017 |
Geskin LJ, Akilov OE, Kwon S, Schowalter M, Watkins S, Whiteside TL, Butterfield LH, Falo LD. Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome. Cancer Immunology, Immunotherapy : Cii. PMID 29204699 DOI: 10.1007/S00262-017-2090-Z |
0.403 |
|
| 2017 |
Mathers AR, Carey CD, Killeen ME, Salvatore SR, Ferris LK, Freeman BA, Schopfer FJ, Falo LD. Topical electrophilic nitro-fatty acids potentiate cutaneous inflammation. Free Radical Biology & Medicine. PMID 29132974 DOI: 10.1016/J.Freeradbiomed.2017.11.009 |
0.303 |
|
| 2017 |
Zhang Y, Liu Z, Hao X, Li A, Zhang J, Carey CD, Falo LD, You Z. Tumor-derived high-mobility group box 1 and thymic stromal lymphopoietin are involved in modulating dendritic cells to activate T regulatory cells in a mouse model. Cancer Immunology, Immunotherapy : Cii. PMID 29116372 DOI: 10.1007/S00262-017-2087-7 |
0.379 |
|
| 2017 |
Duangkhae P, Erdos G, Ryman KD, Watkins SC, Falo LD, Marques ETA, Barratt-Boyes SM. Interplay between Keratinocytes and Myeloid Cells Drives Dengue Virus Spread in Human Skin. The Journal of Investigative Dermatology. PMID 29106931 DOI: 10.1016/J.Jid.2017.10.018 |
0.349 |
|
| 2017 |
Balmert SC, Donahue C, Vu JR, Erdos G, Falo LD, Little SR. In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 261: 223-233. PMID 28694031 DOI: 10.1016/J.Jconrel.2017.07.006 |
0.423 |
|
| 2017 |
Liu Z, Hao X, Zhang Y, Zhang J, Carey CD, Falo LD, Storkus WJ, You Z. Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4(+) T cells combined with agonist α-GITR mAb promotes durable CD8(+) T-cell-dependent antitumor immunity. Oncoimmunology. 6: e1315487. PMID 28680744 DOI: 10.1080/2162402X.2017.1315487 |
0.443 |
|
| 2017 |
Damiano JJ, Patrone CC, Falo LD, Butterfield LH, Kirkwood JM, Geskin LJ. 361 Dendritic cell vaccines for metastatic melanoma Journal of Investigative Dermatology. 137. DOI: 10.1016/J.Jid.2017.02.378 |
0.388 |
|
| 2016 |
Kim E, Erdos G, Huang S, Kenniston T, Falo LD, Gambotto A. Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation. Ebiomedicine. PMID 27717627 DOI: 10.1016/J.Ebiom.2016.09.028 |
0.38 |
|
| 2016 |
Korkmaz E, Friedrich EE, Ramadan MH, Erdos G, Mathers AR, Ozdoganlar OB, Washburn NR, Falo LD. Tip-Loaded Dissolvable Microneedle Arrays Effectively Deliver Polymer-Conjugated Antibody Inhibitors of Tumor-Necrosis-Factor-Alpha Into Human Skin. Journal of Pharmaceutical Sciences. PMID 27544434 DOI: 10.1016/J.Xphs.2016.07.008 |
0.329 |
|
| 2016 |
Sumpter T, Tkacheva O, Falo L, Larregina A. 504 Neurokinin A: A neuropeptide with the potential to inhibit the effector function of cutaneous mast cells Journal of Investigative Dermatology. 136: S89. DOI: 10.1016/J.Jid.2016.02.541 |
0.327 |
|
| 2016 |
Larregina A, Rojas-Canales D, Shufesky W, Tkacheva O, Morelli A, Falo L, Sumpter T. 024 The neurokinin-1 receptor agonists hemokinin-1 and substance P promote T cell activation and survival necessary for chronic inflammatory skin disorders Journal of Investigative Dermatology. 136: S4. DOI: 10.1016/J.Jid.2016.02.048 |
0.313 |
|
| 2015 |
Dulmage BO, Akilov O, Vu JR, Falo LD, Geskin LJ. Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma. Oncotarget. PMID 26556870 DOI: 10.18632/Oncotarget.5742 |
0.339 |
|
| 2015 |
Zhang Y, Chen G, Liu Z, Tian S, Zhang J, Carey CD, Murphy KM, Storkus WJ, Falo LD, You Z. Genetic Vaccines To Potentiate the Effective CD103+ Dendritic Cell-Mediated Cross-Priming of Antitumor Immunity. Journal of Immunology (Baltimore, Md. : 1950). 194: 5937-47. PMID 25972487 DOI: 10.4049/Jimmunol.1500089 |
0.498 |
|
| 2015 |
Dulmage BO, Story SK, Falo LD, Geskin LJ. Novel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma. Leukemia & Lymphoma. 56: 2225-7. PMID 25511681 DOI: 10.3109/10428194.2014.995649 |
0.324 |
|
| 2014 |
Zhang Y, Tian S, Liu Z, Zhang J, Zhang M, Bosenberg MW, Kedl RM, Waldmann TA, Storkus WJ, Falo LD, You Z. Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency. Oncoimmunology. 3: e959321. PMID 25941586 DOI: 10.4161/21624011.2014.959321 |
0.454 |
|
| 2014 |
Sumpter TL, Falo LD. "Toll"-erance in the skin. Immunity. 41: 677-9. PMID 25517608 DOI: 10.1016/J.Immuni.2014.11.003 |
0.371 |
|
| 2014 |
Bediz B, Korkmaz E, Khilwani R, Donahue C, Erdos G, Falo LD, Ozdoganlar OB. Dissolvable microneedle arrays for intradermal delivery of biologics: fabrication and application. Pharmaceutical Research. 31: 117-35. PMID 23904139 DOI: 10.1007/S11095-013-1137-X |
0.304 |
|
| 2014 |
Rothstein SN, Donahue C, Falo LD, Little SR. In silico programming of degradable microparticles to hide and then reveal immunogenic payloads in vivo Journal of Materials Chemistry B. 2: 6183-6187. DOI: 10.1039/C4Tb01042F |
0.357 |
|
| 2013 |
Killeen ME, Ferris L, Kupetsky EA, Falo L, Mathers AR. Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis. Journal of Immunology (Baltimore, Md. : 1950). 190: 4324-36. PMID 23479230 DOI: 10.4049/Jimmunol.1202045 |
0.408 |
|
| 2013 |
Janelsins BM, Sumpter TL, Tkacheva OA, Rojas-Canales DM, Erdos G, Mathers AR, Shufesky WJ, Storkus WJ, Falo LD, Morelli AE, Larregina AT. Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12. Blood. 121: 2923-33. PMID 23365459 DOI: 10.1182/Blood-2012-07-446054 |
0.447 |
|
| 2013 |
Ferris LK, Mburu YK, Mathers AR, Fluharty ER, Larregina AT, Ferris RL, Falo LD. Human beta-defensin 3 induces maturation of human langerhans cell-like dendritic cells: an antimicrobial peptide that functions as an endogenous adjuvant. The Journal of Investigative Dermatology. 133: 460-8. PMID 22951718 DOI: 10.1038/Jid.2012.319 |
0.465 |
|
| 2012 |
Akilov OE, Wu MX, Ustyugova IV, Falo LD, Geskin LJ. Resistance of Sézary cells to TNF-α-induced apoptosis is mediated in part by a loss of TNFR1 and a high level of the IER3 expression. Experimental Dermatology. 21: 287-92. PMID 22417305 DOI: 10.1111/J.1600-0625.2012.01452.X |
0.319 |
|
| 2012 |
Tian S, Liu Z, Donahue C, Falo LD, You Z. Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunity. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 432-42. PMID 21934655 DOI: 10.1038/Mt.2011.183 |
0.479 |
|
| 2012 |
Tüting T, Austyn J, Storkus WJ, Falo LD. The immunology of DNA vaccines. Methods in Molecular Medicine. 29: 37-64. PMID 21374308 DOI: 10.1385/1-59259-688-6:37 |
0.454 |
|
| 2011 |
Liu Z, Falo LD, You Z. Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 187: 118-25. PMID 21642542 DOI: 10.4049/Jimmunol.1003378 |
0.428 |
|
| 2011 |
Akilov OE, Wu MX, Jin Y, Zhou Z, Geskin LJ, Falo LD, Hasan T. Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells. Photodermatology, Photoimmunology & Photomedicine. 27: 97-107. PMID 21392113 DOI: 10.1111/J.1600-0781.2011.00578.X |
0.373 |
|
| 2010 |
Pomerantz RG, Mirvish ED, Erdos G, Falo LD, Geskin LJ. Novel approach to gene expression profiling in Sézary syndrome. British Journal of Dermatology. 163: 1090-1094. PMID 20698843 DOI: 10.1111/J.1365-2133.2010.09973.X |
0.361 |
|
| 2009 |
Sasaki K, Pardee AD, Qu Y, Zhao X, Ueda R, Kohanbash G, Bailey LM, Okada H, Muthuswamy R, Kalinski P, Basse PH, Falo LD, Storkus WJ. IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors. Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 793-802. PMID 19752754 DOI: 10.1097/Cji.0B013E3181Acec1E |
0.388 |
|
| 2009 |
Tian S, Liu Z, Donahue C, Noh HS, Falo LD, You Z. Transcriptional IL-15-directed in vivo DC targeting DNA vaccine. Gene Therapy. 16: 1260-70. PMID 19727134 DOI: 10.1038/Gt.2009.110 |
0.457 |
|
| 2009 |
Liu Z, Tian S, Falo LD, Sakaguchi S, You Z. Therapeutic immunity by adoptive tumor-primed CD4(+) T-cell transfer in combination with in vivo GITR ligation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1274-81. PMID 19417739 DOI: 10.1038/Mt.2009.100 |
0.434 |
|
| 2009 |
Liu Z, Kim JH, Falo LD, You Z. Tumor regulatory T cells potently abrogate antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 182: 6160-7. PMID 19414769 DOI: 10.4049/Jimmunol.0802664 |
0.412 |
|
| 2009 |
Brand RM, Falo LD. Ethanol triggered immune dysfunction is dependent on immunization method Alcohol. 43: 666. DOI: 10.1016/J.Alcohol.2009.09.006 |
0.324 |
|
| 2008 |
Liu Z, Noh HS, Chen J, Kim JH, Falo LD, You Z. Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 181: 4363-70. PMID 18768895 DOI: 10.4049/Jimmunol.181.6.4363 |
0.426 |
|
| 2007 |
He Y, Munn D, Falo LD. Recombinant lentivector as a genetic immunization vehicle for antitumor immunity. Expert Review of Vaccines. 6: 913-24. PMID 18377355 DOI: 10.1586/14760584.6.6.913 |
0.441 |
|
| 2007 |
Nakamura Y, Watchmaker P, Urban J, Sheridan B, Giermasz A, Nishimura F, Sasaki K, Cumberland R, Muthuswamy R, Mailliard RB, Larregina AT, Falo LD, Gooding W, Storkus WJ, Okada H, et al. Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity. Cancer Research. 67: 10012-8. PMID 17942935 DOI: 10.1158/0008-5472.Can-07-1735 |
0.438 |
|
| 2007 |
He Y, Falo LD. Lentivirus as a potent and mechanistically distinct vector for genetic immunization. Current Opinion in Molecular Therapeutics. 9: 439-46. PMID 17932808 |
0.339 |
|
| 2007 |
Storkus WJ, Falo LD. A 'good death' for tumor immunology. Nature Medicine. 13: 28-30. PMID 17206130 DOI: 10.1038/Nm0107-28 |
0.342 |
|
| 2006 |
He Y, Falo LD. Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivector. Immunologic Research. 36: 101-17. PMID 17337771 DOI: 10.1385/Ir:36:1:101 |
0.457 |
|
| 2006 |
Nayak JV, Hokey DA, Larregina A, He Y, Salter RD, Watkins SC, Falo LD. Phagocytosis induces lysosome remodeling and regulated presentation of particulate antigens by activated dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 177: 8493-503. PMID 17142747 DOI: 10.4049/Jimmunol.177.12.8493 |
0.385 |
|
| 2006 |
Vangasseri DP, Cui Z, Chen W, Hokey DA, Falo LD, Huang L. Immunostimulation of dendritic cells by cationic liposomes. Molecular Membrane Biology. 23: 385-95. PMID 17060156 DOI: 10.1080/09687860600790537 |
0.379 |
|
| 2006 |
He Y, Zhang J, Donahue C, Falo LD. Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity. 24: 643-56. PMID 16713981 DOI: 10.1016/J.Immuni.2006.03.014 |
0.496 |
|
| 2005 |
Morelli AE, Rubin JP, Erdos G, Tkacheva OA, Mathers AR, Zahorchak AF, Thomson AW, Falo LD, Larregina AT. CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 175: 7905-15. PMID 16339526 DOI: 10.4049/Jimmunol.175.12.7905 |
0.434 |
|
| 2005 |
Hokey DA, Larregina AT, Erdos G, Watkins SC, Falo LD. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity. Cancer Research. 65: 10059-67. PMID 16267032 DOI: 10.1158/0008-5472.Can-05-1692 |
0.5 |
|
| 2005 |
Kim JH, Majumder N, Lin H, Watkins S, Falo LD, You Z. Induction of therapeutic antitumor immunity by in vivo administration of a lentiviral vaccine. Human Gene Therapy. 16: 1255-66. PMID 16259559 DOI: 10.1089/Hum.2005.16.1255 |
0.481 |
|
| 2005 |
Kim JH, Chen J, Majumder N, Lin H, Falo LD, You Z. ‘Survival gene’ Bcl-xl potentiates DNA-raised antitumor immunity Gene Therapy. 12: 1517-1525. PMID 16052205 DOI: 10.1038/Sj.Gt.3302584 |
0.509 |
|
| 2005 |
Kim JH, Majumder N, Lin H, Chen J, Falo LD, You Z. Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 941-9. PMID 15922965 DOI: 10.1016/J.Ymthe.2005.01.003 |
0.447 |
|
| 2005 |
He Y, Zhang J, Mi Z, Robbins P, Falo LD. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity. Journal of Immunology (Baltimore, Md. : 1950). 174: 3808-17. PMID 15749922 DOI: 10.4049/Jimmunol.174.6.3808 |
0.444 |
|
| 2005 |
Larregina AT, Falo LD. Changing paradigms in cutaneous immunology: adapting with dendritic cells. The Journal of Investigative Dermatology. 124: 1-12. PMID 15654947 DOI: 10.1111/J.1523-1747.2004.23554.X |
0.342 |
|
| 2005 |
Kalinski P, Mailliard RB, Geskin L, Giermasz A, Nakamura Y, Storkus WJ, Lotze MT, Bartlett DL, Kirkwood JM, Falo LD. Polarized DC1-Based Therapeutic Cancer Vaccines Journal of Immunotherapy. 28: 656. DOI: 10.1097/01.Cji.0000191090.97275.78 |
0.341 |
|
| 2004 |
Morelli AE, Larregina AT, Shufesky WJ, Sullivan ML, Stolz DB, Papworth GD, Zahorchak AF, Logar AJ, Wang Z, Watkins SC, Falo LD, Thomson AW. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 104: 3257-66. PMID 15284116 DOI: 10.1182/Blood-2004-03-0824 |
0.388 |
|
| 2004 |
Morel PA, Falkner D, Plowey J, Larregina AT, Falo LD. DNA immunisation: altering the cellular localisation of expressed protein and the immunisation route allows manipulation of the immune response. Vaccine. 22: 447-56. PMID 14670327 DOI: 10.1016/J.Vaccine.2003.07.012 |
0.389 |
|
| 2004 |
Larregina AT, Morelli AE, Tkacheva O, Erdos G, Donahue C, Watkins SC, Thomson AW, Falo LD. Highly efficient expression of transgenic proteins by naked DNA-transfected dendritic cells through terminal differentiation. Blood. 103: 811-9. PMID 14551149 DOI: 10.1182/Blood-2003-02-0524 |
0.437 |
|
| 2004 |
Kalinski P, Mailliard R, Giermasz A, Wankowicz A, Cai Q, Wesa A, Falo L, Storkus W, Kirkwood J. Alpha-Type-1-Polarized DC (αDC1): DC-Based Vaccines with Optimized Anti-Cancer Activity Journal of Immunotherapy. 27: S24. DOI: 10.1097/00002371-200411000-00088 |
0.334 |
|
| 2003 |
Dileo J, Banerjee R, Whitmore M, Nayak JV, Falo LD, Huang L. Lipid-protamine-DNA-mediated antigen delivery to antigen-presenting cells results in enhanced anti-tumor immune responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 7: 640-8. PMID 12718907 DOI: 10.1016/S1525-0016(03)00064-9 |
0.405 |
|
| 2003 |
Morelli AE, Larregina AT, Shufesky WJ, Zahorchak AF, Logar AJ, Papworth GD, Wang Z, Watkins SC, Falo LD, Thomson AW. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood. 101: 611-20. PMID 12393562 DOI: 10.1182/Blood-2002-06-1769 |
0.416 |
|
| 2002 |
Zimmer MI, Larregina AT, Castillo CM, Capuano S, Falo LD, Murphey-Corb M, Reinhart TA, Barratt-Boyes SM. Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS. Blood. 99: 2859-68. PMID 11929776 DOI: 10.1182/Blood.V99.8.2859 |
0.373 |
|
| 2002 |
Lui VW, He Y, Falo L, Huang L. Systemic administration of naked DNA encoding interleukin 12 for the treatment of human papillomavirus DNA-positive tumor. Human Gene Therapy. 13: 177-85. PMID 11812275 DOI: 10.1089/10430340252769716 |
0.329 |
|
| 2002 |
Whitmore MM, Li S, Falo L, Huang L. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunology, Immunotherapy : Cii. 50: 503-14. PMID 11776372 DOI: 10.1007/S002620100227 |
0.377 |
|
| 2001 |
Larregina AT, Morelli AE, Spencer LA, Logar AJ, Watkins SC, Thomson AW, Falo LD. Dermal-resident CD14+ cells differentiate into Langerhans cells Nature Immunology. 2: 1151-1158. PMID 11702065 DOI: 10.1038/Ni731 |
0.399 |
|
| 2001 |
Morelli AE, Zahorchak AF, Larregina AT, Colvin BL, Logar AJ, Takayama T, Falo LD, Thomson AW. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood. 98: 1512-23. PMID 11520802 DOI: 10.1182/Blood.V98.5.1512 |
0.347 |
|
| 2001 |
Hackstein H, Morelli AE, Larregina AT, Ganster RW, Papworth GD, Logar AJ, Watkins SC, Falo LD, Thomson AW. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 166: 7053-62. PMID 11390449 DOI: 10.4049/Jimmunol.166.12.7053 |
0.425 |
|
| 2001 |
Larregina AT, Watkins SC, Erdos G, Spencer LA, Storkus WJ, Beer Stolz D, Falo LD. Direct transfection and activation of human cutaneous dendritic cells Gene Therapy. 8: 608-617. PMID 11320407 DOI: 10.1038/Sj.Gt.3301404 |
0.47 |
|
| 2001 |
Wu X, He Y, Falo LD, Hui KM, Huang L. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein. Molecular Therapy. 3: 368-374. PMID 11273779 DOI: 10.1006/Mthe.2001.0280 |
0.323 |
|
| 2000 |
Larregina AT, Falo LD. Generating and Regulating Immune Responses through Cutaneous Gene Delivery Human Gene Therapy. 11: 2301-2305. PMID 11084690 DOI: 10.1089/104303400750035852 |
0.463 |
|
| 2000 |
Morelli AE, Larregina AT, Ganster RW, Zahorchak AF, Plowey JM, Takayama T, Logar AJ, Robbins PD, Falo LD, Thomson AW. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. Journal of Virology. 74: 9617-28. PMID 11000234 DOI: 10.1128/Jvi.74.20.9617-9628.2000 |
0.412 |
|
| 2000 |
He Y, Pimenov AA, Nayak JV, Plowey J, Falo LD, Huang L. Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo. Human Gene Therapy. 11: 547-54. PMID 10724033 DOI: 10.1089/10430340050015734 |
0.377 |
|
| 2000 |
Barratt-Boyes SM, Zimmer MI, Harshyne LA, Meyer EM, Watkins SC, Capuano S, Murphey-Corb M, Falo LD, Donnenberg AD. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. Journal of Immunology (Baltimore, Md. : 1950). 164: 2487-95. PMID 10679086 DOI: 10.4049/Jimmunol.164.5.2487 |
0.368 |
|
| 2000 |
Morelli AE, Larregina AT, Zahorchak A, Plowey JM, Takayama T, Logar AJ, Robbins PD, Falo LD, Thomson AW. IMPACT OF RECOMBINANT ADENOVIRUS ON DENDRITIC CELL (DC) MATURATION AND FUNCTION: IMPLICATIONS FOR GENETIC ENGINEERING OF DC FOR ANTI-REJECTION THERAPY. Transplantation. 69: S352. DOI: 10.1097/00007890-200004271-00928 |
0.342 |
|
| 1999 |
Hammond SA, Cook SJ, Falo LD, Issel CJ, Montelaro RC. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus. Virology. 254: 37-49. PMID 9927572 DOI: 10.1006/Viro.1998.9550 |
0.414 |
|
| 1999 |
Nayak JV, Falo LD. Antigen delivery to dendritic cells: Implications for cancer immunotherapy Clinical Immunology Newsletter. 19: 131-135. DOI: 10.1016/S0197-1859(00)87087-9 |
0.38 |
|
| 1998 |
Falo LD, Storkus WJ. Giving DNA vaccines a helping hand. Nature Medicine. 4: 1239-40. PMID 9809542 DOI: 10.1038/3217 |
0.373 |
|
| 1998 |
Tüting T, Storkus WJ, Falo LD. DNA immunization targeting the skin: molecular control of adaptive immunity. The Journal of Investigative Dermatology. 111: 183-8. PMID 9699714 DOI: 10.1046/J.1523-1747.1998.00261.X |
0.46 |
|
| 1998 |
Deng J, Falo LD, Kim B, Abell E. Cytotoxic T cells in basal cell carcinomas of skin. American Journal of Dermatopathology. 20: 143-146. PMID 9557782 DOI: 10.1097/00000372-199804000-00007 |
0.39 |
|
| 1997 |
Celluzzi CM, Falo LD. Epidermal Dendritic Cells Induce Potent Antigen-Specific CTL-Mediated Immunity Journal of Investigative Dermatology. 108: 716-720. PMID 9129221 DOI: 10.1111/1523-1747.Ep12292095 |
0.497 |
|
| 1997 |
Lotze MT, Storkus WJ, Falo L, Baar J, Davis I, Tueting T, Esche C, Whiteside TL, Elder EM, Kinzler DM, Paradise C, Kirkwood JM. Dendritic cells (DCs) and the immunotherapy of melanoma Melanoma Research. 7: S4. DOI: 10.1097/00008390-199706001-00012 |
0.403 |
|
| 1996 |
Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD. DNA–based immunization by in vivo transfection of dendritic cells Nature Medicine. 2: 1122-1128. PMID 8837611 DOI: 10.1038/Nm1096-1122 |
0.485 |
|
| 1996 |
Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. The Journal of Experimental Medicine. 183: 283-7. PMID 8551233 DOI: 10.1084/Jem.183.1.283 |
0.454 |
|
| 1995 |
Falo LD, Kovacsovics-Bankowski M, Thompson K, Rock KL. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nature Medicine. 1: 649-653. PMID 7585145 DOI: 10.1038/Nm0795-649 |
0.432 |
|
| 1995 |
Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity Nature Medicine. 1: 1297-1302. PMID 7489412 DOI: 10.1038/Nm1295-1297 |
0.372 |
|
| Show low-probability matches. |